Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Eligibility
Inclusion criteria
Inclusion criteria: All women in the Maternal Newborn Health Registry will be eligible to be screened for the COVID-19 study at time of enrollment into the MNHR. This study will follow the same inclusion and exclusion criteria as the MNH Registry (MNHR) to screen Pregnant women intending to deliver within study cluster
Exclusion criteria
Exclusion criteria: Decline to provide consent to include data in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of COVID-19 antibody positive results during pregnancyTimepoint: Up to 42 days postpartum | — |
Secondary
| Measure | Time frame |
|---|---|
| Fetal/neonatal outcomes: spontaneous abortion, stillbirth, birth weight and fetal growth restriction, early (7-day) and late (28-day) neonatal death, cause of death, congenital infections, and malformationsTimepoint: Up to 42 days postpartum;Knowledge, attitudes, and practices of pregnant women related to COVID-19 infection during pregnancyTimepoint: Up to 42 days postpartum;Maternal outcomes: rate of infection, timing of infection, types of symptoms, death, cause of deathTimepoint: Up to 42 days postpartum | — |
Countries
Bangladesh, Democratic Republic of the Congo, Guatemala, India, Kenya, Pakistan, Zambia
Contacts
Public ContactDr Shivaprasad S Goudar
KLE Academy of Higher Education and Research J N Medical College
Outcome results
None listed